VOGLIDIN 0.2
VOGLIDIN 0.2 contains Voglibose 0.2 mg, an alpha-glucosidase inhibitor used in the treatment of type 2 diabetes to control post-meal blood sugar spikes. It works by slowing carbohydrate digestion in the intestine, reducing the rapid rise of glucose after meals. VOGLIDIN 0.2 helps improve postprandial sugar control and supports better overall glycemic management in diabetic patients.
Related products
LINANTA M 1000
LINANTA M 1000 contains Linagliptin 2.5 mg + Metformin Hydrochloride 1000 mg, a powerful combination...
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes...
GLIPDIP M
GLIPDIP M is used for effective management of type 2 diabetes mellitus. Each tablet contains...
DUET ACT 4
DUET ACT 4 Tablet is a combination medicine used for effective management of type 2...
DUET ACT 3
DUET ACT 3 Tablet is a combination medicine used for managing type 2 diabetes. It...
DAPAGLIDE 5
COMPOSITION : Dapagliflozin 5 mg
